Flow diagram of the selection process for remimazolam-related adverse events.

Flow diagram of the selection process for remimazolam-related adverse events.

<p>The diagram illustrates the stepwise filtering of reports from the FAERS database, showing the number of adverse event (AE) records identified and excluded at each stage to arrive at the final analytical dataset.</p>

Saved in:

Bibliographic Details
Main Author:	Gang Ye (318792) (author)
Other Authors:	Luqin Ding (22110187) (author), Qingbo Zhou (10832646) (author)
Published:	2025
Subjects:	Biotechnology Immunology Cancer Science Policy Space Science Biological Sciences not elsewhere classified severe hypersensitivity reactions reporting odds ratio remained clinically significant proportional reporting ratio concurrent literature review adverse event profile serious adverse events remimazolam &# 8217 detected significant signals serious nature xlink "> study population study aimed strong signal ror ), risk patients risk groups remimazolam demonstrated predominantly elderly novel ultra less pronounced laryngeal edema including cardiac identified signals future research faers database faers data defined period clinical application cardiorespiratory arrest anaphylactic shock acting benzodiazepine
Tags:	Add Tag No Tags, Be the first to tag this record!

Cannot write session to /tmp/vufind_sessions/sess_63uofgd3u1hmh8jt757db0i6ki